Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

TILS.L (TILS) Regulatory News

Date Source Headline
21st Aug 2018 7:00 am RNS PDMR dealings
20th Aug 2018 7:00 am RNS PDMR Dealing
17th Aug 2018 7:00 am RNS PDMR Dealing
16th Aug 2018 9:00 am RNS Filing of Investigational New Drug application
27th Jul 2018 7:00 am RNS US Registration Statement for Proposed Offering
25th Jun 2018 10:49 am RNS Result of AGM
7th Jun 2018 7:01 am RNS Appointment of Broker
7th Jun 2018 7:00 am RNS Final Results
1st Jun 2018 7:00 am RNS Notice of AGM
23rd May 2018 4:40 pm RNS Second Price Monitoring Extn
23rd May 2018 4:35 pm RNS Price Monitoring Extension
16th May 2018 7:00 am RNS Milciclib Phase 2a Trial - Tolerability Update
1st May 2018 3:00 pm RNS Grant of Options - Director Dealing
27th Apr 2018 7:00 am RNS Issue of Equity
19th Apr 2018 7:00 am RNS Subscription
16th Apr 2018 7:25 am RNS License Agreement
9th Apr 2018 8:25 am RNS Presentation at ASCO 3 June 2018
5th Apr 2018 7:00 am RNS Appointment of Broker
4th Apr 2018 7:00 am RNS Appointment of Director
5th Mar 2018 7:00 am RNS Placing to raise £600,000 and issue of equity
2nd Mar 2018 12:09 pm RNS Statement re broker
22nd Jan 2018 7:00 am RNS Placing
16th Jan 2018 7:00 am RNS Placing
15th Dec 2017 7:00 am RNS Placing and Issue of Equity
8th Dec 2017 7:00 am RNS Milciclib Phase 2a Trial Update
27th Nov 2017 7:00 am RNS Placing
23rd Nov 2017 7:00 am RNS Phase II Clinical Trial Update
20th Nov 2017 7:00 am RNS Subscription
29th Sep 2017 7:00 am RNS Interim Results for Six Months Ended 30 June 2017
6th Sep 2017 7:00 am RNS A Proprietary Oral Formulation of Foralumab
31st Aug 2017 11:07 am RNS Grant of options - Director's dealing
16th Aug 2017 7:00 am RNS Conversion of outstanding loan notes
28th Jul 2017 7:00 am RNS Publication of Research Article on Foralumab
19th Jul 2017 7:00 am RNS Initiation of a Phase IIa Clinical Trial
12th Jul 2017 7:00 am RNS Proposed changes to CLNs and Warrant Terms
29th Jun 2017 11:21 am RNS Result of AGM
12th Jun 2017 7:00 am RNS Appointment of Dr Kunwar Shailubhai as CEO
8th Jun 2017 10:02 am RNS NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Jun 2017 8:14 am RNS Bcl-3 pre-clinical update and Director's dealing
1st Jun 2017 7:00 am RNS 2016 Annual Report and Accounts and notice of AGM
FTSE 100 Latest
Value8,809.74
Change53.53